EPIDEMIOLOGY OF CAMPYLOBACTER IN IRELAND

Similar documents
Campylobacter species

11-ID-10. Committee: Infectious Disease. Title: Creation of a National Campylobacteriosis Case Definition

Surveillance of Zoonotic Diseases Foodborne Zoonoses

Campylobacter infections in EU/EEA and related AMR

2010 EU Summary Report on Zoonoses: overview on Campylobacter

Prevention and control of Campylobacter in the poultry production system

Trends and sources of Campylobacter in the EU, covered by EFSA s Community zoonoses summary report

Food-borne Zoonoses. Stuart A. Slorach

Project Summary. Emerging Pathogens in US Cattle

EFSA s activities on Antimicrobial Resistance

Walid Alali Assistant Professor, Food Safety Epidemiology

Marrakech, Morocco, January 2002

The Report referred to in Article 9 of Directive 2003/99/EC

ZOONOSES MONITORING. Luxembourg IN 2014 TRENDS AND SOURCES OF ZOONOSES AND ZOONOTIC AGENTS IN FOODSTUFFS, ANIMALS AND FEEDINGSTUFFS

Campylobacter Risk Management Strategy

Antibiotic Resistance in the European Union Associated with Therapeutic use of Veterinary Medicines

13 May Submission on Campylobacter performance target limits.

Short information about the ZOBA. Participating on proficiency tests. Monitoring programme

SUMMARY REPORT. EFSA SCIENTIFIC COLLOQUIUM No. 12. Assessing health benefits of controlling Campylobacter in the food chain

The Report referred to in Article 5 of Directive 92/117/EEC

Recommendations for a Practical Control Programme for Campylobacter in the Poultry Production and Slaughter Chain

Zoonoses in the EU and global context

Control of Campylobacter in the primary production of Broilers in Denmark

UNITED KINGDOM TRENDS AND SOURCES OF ZOONOSES AND ZOONOTIC AGENTS IN HUMANS, FOODSTUFFS, ANIMALS AND FEEDINGSTUFFS

Originally posted February 13, Update: March 26, 2018

CHRO 2009 in Japan. Summary of presentations of specific interest. Marjaana Hakkinen, Evira Elina Lahti, CRL

2 nd UK-Russia Round Table on AMR. Christopher Teale, Animal and Plant Health Agency. Moscow, st February 2017.

Introduction Coordinating surveillance policies in animal health and food safety from farm to fork

This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents

This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents

DANMAP Danish Integrated Antimicrobial Resistance Monitoring and Research Programme

Salmonella monitoring data, food-borne outbreaks and antimicrobial resistance data for 2014 in the European Union

MICROBIOLOGICAL AND EPIDEMIOLOGICAL INVESTIGATIONS AT THE VLA

CROATIA TRENDS AND SOURCES OF ZOONOSES AND ZOONOTIC AGENTS IN HUMANS, FOODSTUFFS, ANIMALS AND FEEDINGSTUFFS

The WHO Strategy for managing zoonotic public health risks at the human-animal interface

Food borne diseases: the focus on Salmonella

The Report referred to in Article 9 of Directive 2003/ 99/ EC

Health Service Executive Parkgate St. Business Centre, Dublin 8 Tel:

DANMAP and VetStat. Monitoring resistance and antimicrobial consumption in production animals

OIE Reference Laboratory Reports Activities

Having regard to the Treaty establishing the European Community, and in particular Article 152(4)(b) thereof,

Zoonoses in food and feed

Salmonella control programmes in Denmark

FDA Announcement. For Immediate Release. Contact. Announcement. February 13, Consumers

International Food Safety Authorities Network (INFOSAN) Antimicrobial Resistance from Food Animals

Campylobacter control in the food chain. EU proposals on the revision of the hygiene inspection of poultry

Birgitte Borck Høg, Senior Scientific Officer Helle Korsgaard, Senior Scientific Officer Tine Hald, Professor National Food Institute, DTU

FACT SHEETS. On the Danish restrictions of non-therapeutical use of antibiotics for growth promotion and its consequences

ESTONIA TRENDS AND SOURCES OF ZOONOSES AND ZOONOTIC AGENTS IN HUMANS, FOODSTUFFS, ANIMALS AND FEEDINGSTUFFS

The Report referred to in Article 9 of Directive 2003/ 99/ EC

The Report referred to in Article 9 of Directive 2003/99/EC

ARCH-Vet. Summary 2013

Safefood helpline from the South from the North The Food Safety Promotion Board Abbey Court, Lower Abbey Street, Dublin 1

EUROPEAN COMMISSION HEALTH & CONSUMER PROTECTION DIRECTORATE-GENERAL

The Report referred to in Article 9 of Directive 2003/99/EC

Official Journal of the European Union. (Acts whose publication is obligatory)

EFSA s activities on Antimicrobial resistance in the food chain. Dr. Ernesto Liebana Head of BIOCONTAM Unit. EFSA

The EFSA s BIOHAZ Panel perspective on food microbiology and hygiene

Foodborne zoonoses in Switzerland and beyond

Food Safety Risk Profile for Campylobacter species in broiler (young) chickens

FAO-APHCA/OIE/USDA Regional Workshop on Prevention and Control of Neglected Zoonoses in Asia July, 2015, Obihiro, Japan.

ZOONOSES MONITORING. Luxembourg IN 2015 TRENDS AND SOURCES OF ZOONOSES AND ZOONOTIC AGENTS IN FOODSTUFFS, ANIMALS AND FEEDINGSTUFFS

Regional Seminar for OIE National Focal Points for Animal Production Food Safety. Belgrade, Serbia, October

abcde abc a NHS HDL (2002) 89 Dear Colleague 17 December 2002

Antibiotic resistance and the human-animal interface: Public health concerns

RESPONSIBLE ANTIMICROBIAL USE

EFSA s activities on antimicrobial resistance in the food chain: risk assessment, data collection and risk communication.

Official Journal of the European Union L 280/5

64954 Federal Register / Vol. 65, No. 211 / Tuesday, October 31, 2000 / Notices

Frank Møller Aarestrup

The Report referred to in Article 9 of Directive 2003/99/EC

Punto di vista dell EFSA e raccolta dati

SCOTTISH MRSA REFERENCE LABORATORY

of Conferences of OIE Regional Commissions organised since 1 June 2013 endorsed by the Assembly of the OIE on 29 May 2014

EN SANCO/745/2008r6 EN EN

Zoonoses: Austria Dr. Ulrich Herzog World Health Day Foodsafety AGES

ANNEX. to the COMMISSION IMPLEMENTING DECISION

UPDATE ON DEMONSTRATED RISKS IN HUMAN MEDICINE FROM RESISTANT PATHOGENS OF ANIMAL ORIGINS

The Report referred to in Article 9 of Directive 2003/ 99/ EC

The Norwegian Zoonoses Report

Med-Vet-Net Association: embracing one health Anne Ridley MVNA Project Manager AHVLA, Weybridge

SCIENTIFIC REPORT. Analysis of the baseline survey on the prevalence of Salmonella in turkey flocks, in the EU,


UK National Control Programme for Salmonella in chickens (Gallus gallus) reared for meat (Broilers)

Meat contamination by Salmonella, Campylobacter, Yersinia enterocolitica and EHEC O157 in Belgium

Safe Patient Care Keeping our Residents Safe Use Standard Precautions for ALL Residents at ALL times

Questions and answers about methicillin-resistant Staphylococcus aureus (MRSA)

Hospital Infection. Mongolia, October Walter Popp Hospital Hygiene University Clinics Essen, Germany

SCOTTISH MRSA REFERENCE LABORATORY

Drd. OBADĂ MIHAI DORU. PhD THESIS ABSTRACT

SWEDEN TRENDS AND SOURCES OF ZOONOSES AND ZOONOTIC AGENTS IN HUMANS, FOODSTUFFS, ANIMALS AND FEEDINGSTUFFS

Activities of the Centre for Zoonoses, Animal Bacterial Diseases and Antimicrobial Resistance (ZOBA) in Switzerland

Opinion of the Scientific Panel on Biological Hazards on the request from the Commission related to Campylobacter in animals and foodstuffs 1

Risk management of antimicrobial use and resistance from food-producing animals in Denmark

The Report referred to in Article 5 of Directive 92/117/EEC

ESTONIA TRENDS AND SOURCES OF ZOONOSES AND ZOONOTIC AGENTS IN HUMANS, FOODSTUFFS, ANIMALS AND FEEDINGSTUFFS

Risk assessment of the re-emergence of bovine brucellosis/tuberculosis

The Salmonella story by Integrated Surveillance

The European AMR Challenge - strategic views from the human perspective -

AMR in Codex Alimentarius Commission and country responsibilities

Transcription:

EPIDEMIOLOGY OF CAMPYLOBACTER IN IRELAND

Table of Contents Acknowledgements 3 Summary 4 Introduction 5 Case Definitions 6 Materials and Methods 7 Results 8 Discussion 13 References 14 Epidemiology of Campylobacteriosis in Ireland, 2006 Page 2

Acknowledgements The authors wish to thank all who have provided data for this report, including specialists in public health medicine, senior/area medical officers, surveillance scientists, clinical microbiologists, medical scientists, infection control nurses, principal/ environmental health officers. Authorship: Report written by Barbara Foley HPSC and edited by Paul McKeown, HPSC Citation: Epidemiology of Campylobacteriosis in Ireland, 2006. Health Protection Surveillance Centre, Further information: For further information on campylobacter in Ireland, please see: http://www.ndsc.ie/hpsc/a-z/gastroenteric/campylobacter/ Epidemiology of Campylobacteriosis in Ireland, 2006 Page 3

Summary Campylobacter remains the commonest cause of gastroenteritis of bacterial aetiology in Ireland In 2006, there were 1815 cases of campylobacteriosis notified (CIR 42.8/100,000) The highest burden of illness was in children under 5 years of age In 2006, the highest incidence rates were reported from the Western and Midland health board regions Epidemiology of Campylobacteriosis in Ireland, 2006 Page 4

Introduction Campylobacteriosis is the commonest reported bacterial cause of infectious intestinal disease in Ireland. Two species account for the majority of infections: C. jejuni and C. coli. Illness is characterised by severe diarrhoea and abdominal pain. Symptoms may subside after a number of days or may persist for weeks. Rarely, more severe sequelae may develop such as reactive arthritis, Reiter s syndrome, or HUS and approximately 1 in every 1000 cases leads to a severe neurological disorder called Guillain-Barré Syndrome (GBS). Undercooked meat especially poultry is often associated with illness as is unpasteurised milk and untreated water. The majority of infections, however, remain largely unexplained by recognised risk factors for disease. Epidemiology of Campylobacteriosis in Ireland, 2006 Page 5

Case Definitions Clinical description Clinical picture compatible with campylobacter infection e.g. an illness with diarrhoea and / or vomiting of variable severity which may be accompanied by abdominal cramps and fever. Cases may also be asymptomatic. Laboratory criteria for diagnosis Isolation of Campylobacter sp. from any clinical specimen. Case classification Possible: N/A Probable: A clinically compatible case with an epidemiological link Confirmed: A clinically compatible case (symptomatic or asymptomatic) that is laboratory confirmed Taken from Case Definitions for Notifiable Diseases. Infectious Diseases (Amendment No. 3) Regulations 2003 (SI No. 707 of 2003). Available at http://www.hpsc.ie Epidemiology of Campylobacteriosis in Ireland, 2006 Page 6

Materials and Methods Human campylobacter infection became a statutorily notifiable disease for the first time in January 2004 under the Amendment to the Infectious Diseases Regulations. 1 Therefore since then, the data on campylobacteriosis has been collated directly from the notifiable disease data on CIDR and not as part of the EU Zoonoses Directive data collection (as had been the case since 1999). Data analysis for this report was performed using Business Objects Reporting in CIDR and MS Excel. Census of Population 2006 figures were used as denominator data in the calculation of incidence rates. The salmonellosis data from CIDR presented in this report are based on data extracted from the CIDR system on 23 rd July 2007. These figures may differ from those published previously, due to ongoing updating of notification data on CIDR. Epidemiology of Campylobacteriosis in Ireland, 2006 Page 7

Results Incidence In total, 1815 notifications of human campylobacteriosis were notified in 2006 in Ireland. This gives a crude incidence rate (CIR) of 42.8 cases per 100,000 population (Table 1). This compared with a CIR of 42.5 cases per 100,000 in 2005 (based on 2006 census data). The annual number of cases by year since 1999 is shown in Figure 1. Table 1: Number of cases and CIR per 100,000 population of human campylobacteriosis in Ireland by health board, 2006. Region No. of CIR (95% CI) ASIR (95% CI) cases HSE-ER 670 44.7 [41.3-48.1] 43.2 [39.9 46.5] HSE-M 127 50.5 [41.7-59.2] 49.4 [40.8-58.0] HSE-MW 132 36.6 [30.3-42.8] 37.0 [30.7 43.3] HSE-NE 123 31.2 [25.7-36.7] 30.8 [25.4-36.3] HSE-NW 105 44.3 [35.8-52.7] 44.6 [36.0-53.2] HSE-SE 197 42.7 [36.8-48.7] 42.8 [36.8 48.8] HSE-S 256 41.2 [36.2-42.3] 41.8 [36.6-46.9] HSE-W 205 49.5 [42.7-56.3] 50.1 [43.2-57.0] Ireland 1815 42.8 [40.8-44.8] 42.6 [40.6-44.6] 2500 2000 Number of cases 1500 1000 500 0 1999 2000 2001 2002 2003 2004 2005 2006 Year Figure 1. Annual number of cases of campylobacteriosis in Ireland, 1999-2006 Epidemiology of Campylobacteriosis in Ireland, 2006 Page 8

Age standardised rates were calculated to allow comparisons to be made between health board regions without the confounding effects of age (Figure 2). In 2006, the highest incidence was reported from the HSE-W region followed by the HSE-M region. The lowest rate was reported from the HSE- NE region (see Figure 2 and corresponding data in Table 1). 70.00 60.00 Rate per 100,000 population 50.00 40.00 30.00 20.00 10.00 CIR ASIR 0.00 HSE-ER HSE-M HSE-MW HSE-NE HSE-NW HSE-SE HSE-S HSE-W Ireland HSE region Figure 2. Age standardised incidence rates (ASIR) of human campylobacteriosis in Ireland, compared to crude incidence rates (CIR) in each health board, 2006. Seasonal distribution Campylobacter has a well documented seasonal distribution with a peak in cases seen every year in early summer. In 2006, a rise in cases was observed from week 21 to week 26 (Figure 3). This was not as definite a peak as seen in previous years. 70 60 Number of cases 50 40 30 20 10 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 Week Number Figure 3. Total cases of campylobacteriosis events by week, 2006 Epidemiology of Campylobacteriosis in Ireland, 2006 Page 9

Age When the distribution of cases for each age group is examined, it is evident that by far the highest burden of illness is seen in children less than five years (Figure 4). This was also noted in previous years and is a well-reported feature of campylobacteriosis. 160 140 120 Incidence Rate 100 80 60 40 20 0 0-4 5-9 10-14 15-19 20-24 25-34 35-44 45-54 55-64 65+ Age Group (Years) Figure 4: Age specific incidence rates for campylobacteriosis in Ireland, 2006 Gender distribution Females accounted for 44.4% of all cases notified; males 55.2% (unknown 0.4%) (Table 2). However the variance in gender distribution that has been noted since 1999 was again evident when the data was adjusted for age and sex. In almost all age-groups there is a predominance of male cases (Figure 5). Table 2. Gender distribution of campylobacter cases by health board region, 2006. Region Female Male Unknown Total HSE-ER 305 360 5 670 HSE-M 49 78 0 127 HSE-MW 59 73 0 132 HSE-NE 69 54 0 123 HSE-NW 46 59 0 105 HSE-SE 90 107 0 197 HSE-S 103 151 2 256 HSE-W 84 119 2 205 Total 805 1001 9 1815 Epidemiology of Campylobacteriosis in Ireland, 2006 Page 10

Age-gender standardised rate 180 160 140 120 100 80 60 40 20 0 0-4 5-9 10-14 15-19 20-24 25-34 35-44 45-54 55-64 65+ Males Females Age-group Figure 5. Age-gender adjusted incidence of campylobacteriosis according to age group in 2006. Typing data Campylobacter typing data was available for 38% (692/1815) of isolates. Of these, 629 (91%) were reported as C. jejuni; 58 (8%) as C. coli; 3 cases as C. lari, and one case each of C. laridis and C. fetus. Country of infection Information on country of infection was available for 12% (218/1815) of cases of campylobacteriosis. Of these 198 (91%) were noted to have been acquired within Ireland, with just 9% associated with travel outside of Ireland. Spain and India were the most commonly reported countries (4 cases each). Outbreak data There were eleven family outbreaks of campylobacteriosis notified resulting in 25 cases of illness in 2006. Epidemiology of Campylobacteriosis in Ireland, 2006 Page 11

Discussion Analysis of the 2006 data reveals that campylobacteriosis still remains the most common cause of bacterial gastroenteric infection in Ireland with over four times the number of salmonellosis cases reported in 2006. The crude incidence rate (CIR) of campylobacteriosis increased in Ireland in 2006 (42.8 cases/100,000 persons) compared to 2005 (42.5/100,000). This was in fact the highest rate reported in Ireland since the year 1999 and represents an increasing trend since 2001. For the same period, higher rates were noted for Northern Ireland (53.9/100,000), England and Wales 1,2 (87.3/100,000) and Scotland 3 (95.3/100,000). Campylobacter is a zoonotic pathogen with some very interesting epidemiologic features. The data in 2006 again reflects the higher incidence in young children and the bias towards male cases in almost all age groups. However, many of the risk factors associated with Campylobacter infection in humans are still poorly understood. Some of these issues were discussed at a major international conference on Campylobacter, Helicobacter and Related Organisms (CHRO) held in September 2007 in the Netherlands 4, presenting up to date research in areas such as epidemiology, typing, genomics and pathogenesis, and risk assessment and control. Many approaches have been taken in different countries around the world in an attempt to control spread of this pathogen. New Zealand, which has a particularly high rate of campylobacteriosis, has applied a quantitative risk model in the poultry food chain from entry to primary processing until consumption, in order to assess risk management interventions 5. Their studies have concluded that poultry is the most important vehicle for Campylobacter transmission in New Zealand. In addition, they were able to show that exposure to the pathogen through food preparation activity and cross contamination to other foods, was greater that either undercooking or poultry purchase. Epidemiology of Campylobacteriosis in Ireland, 2006 Page 12

Denmark is another country that has developed a number of novel intervention strategies aimed at reducing levels of Campylobacter in broiler meat 6. These have included reducing infection at farm level (biosecurity measures), reducing the concentration of Campylobacter on chicken meat at slaughter house level (e.g. by allocating meat from positive flocks to the production of frozen products) and thirdly a consumer education programme. The results of this intervention which took place in 2001 were that the percentage of Campylobacter positive broiler flocks decreased significantly and a decrease in human cases was also observed from 2001 to 2006. It is widely accepted that the genomic diversity of this pathogen has hindered development of a gold standard typing method. In recent years however, development of new innovative molecular methods such as MLST have enabled us to begin our understanding of the epidemiology and diversity of Campylobacter spp 7. It is hoped that further research in this area will help to identify key subtypes that are distributed throughout distinct populations in order to track this pathogen through the food chain. Although our rates of campylobacteriosis in Ireland are not as high as in the UK, the upward trend in incidence since 2001 is of concern. Efforts must continue to control this zoonotic pathogen which continues to be a significant public health concern, both in terms of burden of human illness and economic costs. The recent formation of a National Zoonoses Committee should enable collaborative strategies to be developed for targeted and enhanced control of campylobacteriosis in Ireland. Epidemiology of Campylobacteriosis in Ireland, 2006 Page 13

References 1. Health Protection Agency Centre for Infections. http://www.hpa.org.uk/infections/topics_az/topics.asp?category=a 2. Communicable Disease Surveillance Centre, Northern Ireland www.cdscni.org.uk 3. HPS Weekly Report. Gastrointestinal and foodborne infections. Surveillance Report. (2007) 47:1 3-5. 4. Conference on Campylobacter, Helicobacter and Related Organisms (CHRO) http://www.chro2007.nl 5. Lake RJ, Bayne G, Cressey P, Hudson JA, Van der Logt P. Quantitative risk model: Campylobacter in poultry in New Zealand. Zoonoses Pub Health (2007) 54 (Suppl. 1). 19-155 (O048). 6. Borck B, Galliano C, Nordentoft S, Ethelberg S, Boysen L, Helwigh B, Rosenquist H. Effects of the Danish intervention strategies aimed at reducing Campylobacter in broiler meat.. Zoonoses Pub Health (2007) 54 (Suppl. 1). 19-155 (O046). 7. Sopwith W, Birtles A, Matthews M, Fox A, Gee S, Painter M, Regan M, Syed Q, Bolton E. Campylobacter jejuni multilocus sequence types in humans, northwest England, 2003-2004. Emerg Infect Dis. (2006) 12:1500-7. Epidemiology of Campylobacteriosis in Ireland, 2006 Page 14